BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10421801)

  • 41. p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma.
    MacKinnon M; Kerr KM; King G; Kennedy MM; Cockburn JS; Jeffrey RR
    Eur J Cardiothorac Surg; 1997 May; 11(5):838-42. PubMed ID: 9196297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
    Krause FS; Feil G; Bichler KH
    Anticancer Res; 2000; 20(6D):5023-8. PubMed ID: 11326661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of meiosis regulators in human gonads: a sexually dimorphic spatio-temporal expression pattern suggests involvement of DMRT1 in meiotic entry.
    Jørgensen A; Nielsen JE; Blomberg Jensen M; Græm N; Rajpert-De Meyts E
    Mol Hum Reprod; 2012 Nov; 18(11):523-34. PubMed ID: 22899867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells.
    Liu F; Qi HL; Chen HL
    J Cancer Res Clin Oncol; 2000 Feb; 126(2):85-90. PubMed ID: 10664247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of the nm23-H1 gene in the metastasis of gastric cancer.
    Hwang BG; Park IC; Park MJ; Moon NM; Choi DW; Hong WS; Lee SH; Hong SI
    J Korean Med Sci; 1997 Dec; 12(6):514-8. PubMed ID: 9443089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anti-metastasis gene nm23 expression in buccal cancer studied by immunohistochemistry stain].
    Lu Y; Zhou Z; He Z; Yang C
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):367-70. PubMed ID: 8732053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 'Anti-metastatic' nm23 gene product expression in keratoacanthoma and squamous cell carcinoma.
    Stephenson TJ; Royds JA; Bleehen SS; Silcocks PB; Rees RC
    Dermatology; 1993; 187(2):95-9. PubMed ID: 8358113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation and characterization of the promoter region of human nm23-H1, a metastasis suppressor gene.
    Chen HC; Wang L; Banerjee S
    Oncogene; 1994 Oct; 9(10):2905-12. PubMed ID: 8084595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential expression of nucleoside diphosphate kinases (NDPK/NM23) during Xenopus early development.
    Ouatas T; Sélo M; Sadji Z; Hourdry J; Denis H; Mazabraud A
    Int J Dev Biol; 1998 Jan; 42(1):43-52. PubMed ID: 9496785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of the c-erb B-2, nm23, bcl-2 and p53 protein markers on colorectal cancer.
    Demirbaş S; Sücüllü I; Yildirim S; Celenk T
    Turk J Gastroenterol; 2006 Mar; 17(1):13-9. PubMed ID: 16830272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of the human nm23-H2 promoter region and localization of the microsatellite D17S396.
    Seifert M; Seib T; Engel M; Dooley S; Welter C
    Biochem Biophys Res Commun; 1995 Oct; 215(3):910-4. PubMed ID: 7488060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study on the metastatic mechanisms of human giant-cell lung carcinoma comparison between the strains C and D.
    Mei L; Lezhen C; Po Z; Zheng G; Yali L; Nan L
    Asian Pac J Allergy Immunol; 1998 Dec; 16(4):167-76. PubMed ID: 10219898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification.
    Hailat N; Keim DR; Melhem RF; Zhu XX; Eckerskorn C; Brodeur GM; Reynolds CP; Seeger RC; Lottspeich F; Strahler JR
    J Clin Invest; 1991 Jul; 88(1):341-5. PubMed ID: 2056128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The oncoproteins c-erb-B2, c-fos and the tumour suppressor protein p53 in human embryos and fetuses.
    Miosge N; Schneider W; Götz W; Herken R
    Anat Embryol (Berl); 1997 Apr; 195(4):345-52. PubMed ID: 9108200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oncogenes and cell death.
    Harrington EA; Fanidi A; Evan GI
    Curr Opin Genet Dev; 1994 Feb; 4(1):120-9. PubMed ID: 8193531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oncogenes and tumor suppressor genes.
    Lee EY; Muller WJ
    Cold Spring Harb Perspect Biol; 2010 Oct; 2(10):a003236. PubMed ID: 20719876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apoptosis and predisposition to oral cancer.
    Polverini PJ; Nör JE
    Crit Rev Oral Biol Med; 1999; 10(2):139-52. PubMed ID: 10759418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Developmental expression of morphoregulatory genes in the mouse embryo: an analytical approach using a novel technology.
    Craig JC; Eberwine JH; Calvin JA; Wlodarczyk B; Bennett GD; Finnell RH
    Biochem Mol Med; 1997 Apr; 60(2):81-91. PubMed ID: 9169087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor suppressors: a developing role for p53?
    Hall PA; Lane DP
    Curr Biol; 1997 Mar; 7(3):R144-7. PubMed ID: 9162475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene-targeting approaches in the study of cellular processes involved in growth or differentiation. Advances in the analysis of oncogenes, tumour-suppressor genes, cytokine/receptor systems and developmental control genes.
    Yamada G; Sugimura K; Stuart ET
    Eur J Biochem; 1994 Dec; 226(3):739-49. PubMed ID: 7813464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.